BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16609017)

  • 1. Quantitative analysis of human telomerase reverse transcriptase in pancreatic cancer.
    Ohuchida K; Mizumoto K; Yamada D; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2066-9. PubMed ID: 16609017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer.
    Ohuchida K; Mizumoto K; Ogura Y; Ishikawa N; Nagai E; Yamaguchi K; Tanaka M
    Clin Cancer Res; 2005 Mar; 11(6):2285-92. PubMed ID: 15788678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sonic hedgehog is an early developmental marker of intraductal papillary mucinous neoplasms: clinical implications of mRNA levels in pancreatic juice.
    Ohuchida K; Mizumoto K; Fujita H; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2006 Sep; 210(1):42-8. PubMed ID: 16794990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of human telomerase reverse transcriptase (hTERT) expression in tissue and pancreatic juice from pancreatic cancer.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Fukuda E; Sueda T; Hiyama E
    Surgery; 2008 Jan; 143(1):113-25. PubMed ID: 18154939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of pancreatic adenocarcinoma by detection of human telomerase reverse transcriptase messenger RNA in pancreatic juice with sample qualification.
    Seki K; Suda T; Aoyagi Y; Sugawara S; Natsui M; Motoyama H; Shirai Y; Sekine T; Kawai H; Mita Y; Waguri N; Kuroiwa T; Igarashi M; Asakura H
    Clin Cancer Res; 2001 Jul; 7(7):1976-81. PubMed ID: 11448913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of human telomerase reverse transcriptase in pancreatic juice as a biomarker of pancreatic malignancy.
    Nakashima A; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Oda M; Sueda T; Hiyama E
    Pancreas; 2009 Jul; 38(5):527-33. PubMed ID: 19342980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ.
    Liu J; Baykal A; Fung KM; Thompson-Lanza JA; Hoque A; Lippman SM; Sahin A
    Int J Oncol; 2004 Apr; 24(4):879-84. PubMed ID: 15010825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A6 is increased in a stepwise manner during pancreatic carcinogenesis: clinical value of expression analysis in 98 pancreatic juice samples.
    Ohuchida K; Mizumoto K; Yu J; Yamaguchi H; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):649-54. PubMed ID: 17416753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.
    Takihana Y; Tsuchida T; Fukasawa M; Araki I; Tanabe N; Takeda M
    Int J Urol; 2006 Apr; 13(4):401-8. PubMed ID: 16734859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
    Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
    Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer.
    Kumari A; Srinivasan R; Vasishta RK; Wig JD
    Ann Surg Oncol; 2009 Apr; 16(4):1051-9. PubMed ID: 19194757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomerase gene expression in intraductal papillary-mucinous tumors (IPMT): preliminary findings.
    Nodari F; Baiocchi GL; Salvi A; De Petro G; Coniglio A; Ferrari Bravo A; Baronchelli C; Barlati S; Giulini SM
    Acta Biomed; 2003; 74 Suppl 2():59-64. PubMed ID: 15055037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: analysis of 100 samples of pancreatic juice from consecutive patients.
    Ohuchida K; Mizumoto K; Ishikawa N; Sato N; Nagai E; Yamaguchi K; Takaishi H; Ide T; Tanaka M
    Cancer; 2004 Nov; 101(10):2309-17. PubMed ID: 15476274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the full-length telomerase reverse transcriptase (hTERT) transcript in both malignant and normal gastric tissues.
    Li W; Li L; Liu Z; Liu C; Liu Z; Strååt K; Björkholm M; Jia J; Xu D
    Cancer Lett; 2008 Feb; 260(1-2):28-36. PubMed ID: 18037230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100P is an early developmental marker of pancreatic carcinogenesis.
    Ohuchida K; Mizumoto K; Egami T; Yamaguchi H; Fujii K; Konomi H; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 2006 Sep; 12(18):5411-6. PubMed ID: 17000674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
    Saebøe-Larssen S; Fossberg E; Gaudernack G
    BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
    Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of hTERT mRNA expression in biliary tract and pancreatic cancer.
    Kawahara R; Odo M; Kinoshita H; Shirouzu K; Aoyagi S
    J Hepatobiliary Pancreat Surg; 2007; 14(2):189-93. PubMed ID: 17384912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.